Table 2 MACE rates (n/1000), and unadjusted HR for tertiles of urinary sodium excretion with their 95% confidence interval
Tertile 1 (< 173 mmol/day) (n = 61) | Tertile 2 (173 -229 mmol/day) (n = 59) | Tertile 3 (230–491 mmol/day) (n = 60) | |
|---|---|---|---|
Median survival analysis time (years) [IQR] | 10.3 years [3.6–20.9] | 14.3 years [7.5–27.2] | 12.8 years [12.8–21.4] |
MACE | 42 | 37 | 35 |
total follow-up (1000 person years) | 0.75 | 0.97 | 0.86 |
Rate (per 1000 person years)2 | 55.89 (41.30, 75.62) | 37.85 (27.42, 52.23) | 40.77 (29.28, 56.79) |
Unadjusted HR | REF | 0.68 (0.43, 1.05) | 0.73 (0.46, 1.14) |
P value | REF | 0.084 | 0.163 |